209 related articles for article (PubMed ID: 31328722)
1. Potential Five-MicroRNA Signature Model for the Prediction of Prognosis in Patients with Wilms Tumor.
Gong Y; Zou B; Chen J; Ding L; Li P; Chen J; Chen J; Zhang B; Li J
Med Sci Monit; 2019 Jul; 25():5435-5444. PubMed ID: 31328722
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Biomarkers in Wilms' Tumor.
Zheng H; Li BH; Liu C; Jia L; Liu FT
Biomed Res Int; 2020; 2020():4951692. PubMed ID: 32149111
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of a Long Noncoding RNA-Associated Competing Endogenous RNA Network in Wilms Tumor.
Zhang F; Zeng L; Cai Q; Xu Z; Liu R; Zhong H; Mukiibi R; Deng L; Tang X; Xin H
Cancer Control; 2020; 27(2):1073274820936991. PubMed ID: 32597194
[TBL] [Abstract][Full Text] [Related]
4. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of long non‑coding RNA using an associated competitive endogenous RNA network in Wilms tumor.
Wang Z; Cheng H; Qi L; Sui D
Mol Med Rep; 2020 Jul; 22(1):105-116. PubMed ID: 32377711
[TBL] [Abstract][Full Text] [Related]
6. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
7. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
Liu M; Zhu K; Qian X; Li W
Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
[TBL] [Abstract][Full Text] [Related]
8. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
Xu Y; Chen J; Yang Z; Xu L
Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
[TBL] [Abstract][Full Text] [Related]
9. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
[TBL] [Abstract][Full Text] [Related]
10. An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma.
Dou D; Yang S; Lin Y; Zhang J
Cancer Biomark; 2018; 23(1):79-93. PubMed ID: 29991127
[TBL] [Abstract][Full Text] [Related]
11. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
Sharma P; Saraya A; Sharma R
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
[TBL] [Abstract][Full Text] [Related]
12. Identification of a five-mRNA signature as a novel potential prognostic biomarker in pediatric Wilms tumor.
Lin XD; Wu YP; Chen SH; Sun XL; Ke ZB; Chen DN; Li XD; Lin YZ; Wei Y; Zheng QS; Xu N; Xue XY
Mol Genet Genomic Med; 2020 Jan; 8(1):e1032. PubMed ID: 31701684
[TBL] [Abstract][Full Text] [Related]
13. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
[TBL] [Abstract][Full Text] [Related]
14. Potential four‑miRNA signature associated with T stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co‑expression analysis.
You L; Wang J; Zhang F; Zhang J; Tao H; Zheng X; Hu Y
Mol Med Rep; 2019 Jan; 19(1):441-451. PubMed ID: 30483731
[TBL] [Abstract][Full Text] [Related]
15. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
Liu H; Liu L; Zhu H
J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
[TBL] [Abstract][Full Text] [Related]
16. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
17. Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
Lv Y; Duanmu J; Fu X; Li T; Jiang Q
PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961
[TBL] [Abstract][Full Text] [Related]
18. Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma.
Zheng R; Mao W; Du Z; Zhang J; Wang M; Hu M
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):377-382. PubMed ID: 30442364
[TBL] [Abstract][Full Text] [Related]
19. Weighted gene co‑expression network analysis for identifying hub genes in association with prognosis in Wilms tumor.
Wang X; Song P; Huang C; Yuan N; Zhao X; Xu C
Mol Med Rep; 2019 Mar; 19(3):2041-2050. PubMed ID: 30664180
[TBL] [Abstract][Full Text] [Related]
20. Establishment of the Prognosis Predicting Signature for Endometrial Cancer Patient.
Tang J; Ma W; Luo L
Med Sci Monit; 2019 Nov; 25():8248-8259. PubMed ID: 31678981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]